DAWN CHILDS: Open Payments
NPI 1912285669 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,070 in 128 payments from 22 companies in 2025. Trend: 2023 $2,312 · 2024 $2,141 · 2025 $2,070
Food & beverage: $2,070
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $433 |
| AstraZeneca Pharmaceuticals LP | 12 | $373 |
| Novo Nordisk Inc | 13 | $193 |
| Lilly USA, LLC | 15 | $188 |
| PFIZER INC. | 18 | $171 |
| Abbott Laboratories | 9 | $149 |
| Vanda Pharmaceuticals Inc. | 4 | $118 |
| Axsome Therapeutics, Inc. | 5 | $86 |
| Astellas Pharma US Inc | 3 | $52 |
| Bausch Health US, LLC | 2 | $46 |
Products named: AIRSUPRA, VRAYLAR, FREESTYLE LIBRE 3, NURTEC ODT, MOUNJARO, UBRELVY, FANAPT, Auvelity.
Industry payments across MO — which companies pay providers there.
